data_1ght_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ght _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.45 -0.574 . . . . 1.73 109.45 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -146.6 169.71 18.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 2.9199999999999999 109.498 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.05 83.45 1.83 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.613 -0.679 . . . . 1.5 109.702 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -82.79 145.02 29.75 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.04 -0.726 . . . . 2.25 109.04 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.24 129.35 5.54 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.124 -1.19 . . . . 0.48999999999999999 110.124 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.428 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 30.4 t80 -95.05 136.34 35.49 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.605 -0.887 . . . . 2.1899999999999999 108.605 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.92 158.06 44.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.381 -0.824 . . . . 1.1799999999999999 110.359 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -155.84 130.25 8.92 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.762 -1.199 . . . . 2.5 107.762 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 15' ' ' SER . 28.2 m -85.4 145.75 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.428 -0.795 . . . . 1.25 111.06 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t -120.51 -39.49 2.76 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.922 -0.77 . . . . 1.3999999999999999 108.922 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.5 t -85.08 171.1 12.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 1.3500000000000001 109.445 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -114.08 53.6 0.78 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.561 -0.712 . . . . 1.9399999999999999 109.797 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -133.11 -57.51 0.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.376 -0.828 . . . . 2.9700000000000002 109.203 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -174.74 40.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.625 -0.88 . . . . 2.6299999999999999 108.625 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -58.44 -33.68 69.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.732 -0.605 . . . . 2.1000000000000001 110.142 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.61 -42.3 96.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.267 -0.896 . . . . 1.3400000000000001 108.762 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.75 -49.3 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.52 -0.919 . . . . 1.25 108.52 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 mt -61.11 -38.66 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.699 -0.626 . . . . 1.26 109.43 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -64.54 -53.89 40.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.175 -0.676 . . . . 2.7799999999999998 109.175 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -50.22 -49.43 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.694 -0.629 . . . . 1.1000000000000001 109.607 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -58.51 -31.46 67.91 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.6 -0.889 . . . . 4.46 108.6 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.82 -40.08 69.38 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.079 -0.711 . . . . 1.0900000000000001 109.079 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.41 -44.49 67.81 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.484 -0.932 . . . . 1.73 108.484 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -45.43 93.98 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.001 -0.74 . . . . 2.3799999999999999 109.001 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -59.79 -34.18 72.69 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.453 -0.943 . . . . 1.28 108.453 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.58 -32.81 70.34 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.185 -0.672 . . . . 1.1100000000000001 109.185 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.56 45.85 0.26 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.35 -1.9 . . . . 0.5 108.35 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.8 t -119.64 145.77 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.927 -0.749 . . . . 1.29 109.287 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.0 140.63 31.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 1.6499999999999999 109.159 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.68 -32.86 74.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.561 -0.712 . . . . 1.1499999999999999 109.346 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.4 -26.24 68.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.621 -0.674 . . . . 0.54000000000000004 109.34 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.37 65.56 0.64 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.467 -0.771 . . . . 2.3900000000000001 109.388 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.5 mm -117.49 87.51 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 1.1200000000000001 109.21 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -81.41 74.83 8.39 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.924 -0.769 . . . . 2.1099999999999999 108.924 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 t -78.95 178.06 8.29 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.403 0.621 . . . . 1.46 110.124 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.61 107.27 5.9 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.145 -0.687 . . . . 1.3600000000000001 109.145 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -72.41 65.55 0.64 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.734 . . . . 2.0899999999999999 109.346 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.81 47.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.351 -0.843 . . . . 1.29 110.152 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -71.8 66.47 0.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -0.77 . . . . 2.2799999999999998 109.593 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.46 -154.47 6.15 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.349 -1.5 . . . . 2.21 109.349 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -63.76 -33.29 75.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.976 . . . . 3.1000000000000001 109.311 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 m -153.03 -175.58 5.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 2.5299999999999998 109.319 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.16 128.02 34.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.466 -0.771 . . . . 2.1400000000000001 109.592 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.78 69.4 1.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 2.0099999999999998 109.387 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -74.98 74.08 2.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.401 -0.812 . . . . 3.7200000000000002 109.666 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -112.89 -21.27 11.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.448 -0.783 . . . . 3.0099999999999998 109.86 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.32 -68.34 1.73 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.777 -1.329 . . . . 0.81999999999999995 109.777 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' HG ' ' CZ ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -62.66 -30.4 71.35 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.646 -0.914 . . . . 2.0299999999999998 108.824 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -59.52 -39.23 83.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 1.6100000000000001 109.314 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 mt -92.04 -28.69 17.01 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.696 -0.853 . . . . 1.29 108.696 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.07 -36.44 81.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.559 -0.713 . . . . 1.05 109.117 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 32.6 mtp180 -61.53 -23.56 66.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.527 -0.733 . . . . 1.6499999999999999 109.586 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -112.82 4.24 16.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.491 -0.755 . . . . 2.9700000000000002 111.174 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -113.18 -25.06 9.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.073 -1.017 . . . . 2.3199999999999998 110.486 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.426 HG13 ' CE1' ' A' ' 83' ' ' PHE . 30.0 m -62.56 146.25 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.373 -0.829 . . . . 1.5800000000000001 109.876 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -101.97 167.02 10.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.603 -0.686 . . . . 2.2799999999999998 109.242 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.01 111.2 3.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.414 -0.804 . . . . 2.1299999999999999 109.611 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.26 24.54 16.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.886 -1.286 . . . . 0.46000000000000002 109.886 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.26 157.12 17.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -1.083 . . . . 2.1400000000000001 109.525 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.71 126.69 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.556 -0.715 . . . . 1.6699999999999999 109.176 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.9 mt -103.48 99.8 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.997 -0.742 . . . . 1.0800000000000001 108.997 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mt -78.98 121.83 25.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.666 -0.646 . . . . 1.47 109.376 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.86 139.75 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.507 -0.746 . . . . 1.6499999999999999 109.447 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -99.74 162.83 12.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.594 -0.692 . . . . 4.1500000000000004 109.331 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.37 85.49 2.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 4.0499999999999998 109.543 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.0 tp -106.49 -33.87 7.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.704 . . . . 2.21 109.245 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.06 -75.97 0.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.588 -0.695 . . . . 3.7799999999999998 109.426 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 179.85 138.6 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.629 -0.669 . . . . 5.1299999999999999 109.243 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' HG ' ' CG ' ' A' ' 76' ' ' MET . 4.4 mm? -57.01 -66.51 0.44 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.534 -0.729 . . . . 2.0499999999999998 110.276 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.75 -125.2 5.13 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.686 -1.365 . . . . 1.98 109.686 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -171.76 -59.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.639 -0.918 . . . . 6.8499999999999996 109.488 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.01 -65.58 1.05 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.511 -0.743 . . . . 3.1200000000000001 109.496 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 m -60.8 167.79 2.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.501 -0.749 . . . . 2.6400000000000001 109.707 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.71 62.08 1.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.622 -0.674 . . . . 1.46 109.58 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -78.79 -50.77 10.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 1.99 108.974 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.419 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 1.4 tmt? -56.24 -35.28 67.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 3.5 109.681 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.95 -20.23 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.756 -0.59 . . . . 1.3300000000000001 109.89 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -69.17 0.26 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.241 -0.912 . . . . 3.1099999999999999 109.433 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' O ' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -58.19 -17.37 18.36 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.531 -0.731 . . . . 2.1099999999999999 110.701 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.37 -42.35 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.838 -1.171 . . . . 1.9099999999999999 107.838 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -32.38 70.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.482 -0.933 . . . . 2.7999999999999998 108.482 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.35 -42.21 79.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.48 -0.563 . . . . 1.98 109.48 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.426 ' CE1' HG13 ' A' ' 55' ' ' VAL . 20.8 m-85 -76.27 -35.47 58.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -0.758 . . . . 2.2799999999999998 109.453 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.76 -35.24 75.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 1.3500000000000001 109.482 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.39 -23.82 37.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.694 -0.629 . . . . 1.1899999999999999 110.035 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.81 4.85 23.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 2.3199999999999998 110.461 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.1 28.65 66.03 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.362 -1.495 . . . . 0.48999999999999999 109.362 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.6 t -114.43 148.82 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.658 -0.907 . . . . 1.1499999999999999 109.045 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -104.4 164.73 11.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 0.94999999999999996 109.517 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.8 mt -137.36 105.11 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.724 -0.843 . . . . 1.0900000000000001 108.724 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -77.63 153.79 32.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.529 -0.732 . . . . 2.5899999999999999 109.522 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.91 119.99 25.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.574 -0.703 . . . . 2.4900000000000002 109.879 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.4 -22.52 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.516 -0.74 . . . . 2.3399999999999999 109.728 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -62.89 -26.29 68.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 2.7400000000000002 110.305 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -137.22 -44.04 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.337 -0.852 . . . . 2.9500000000000002 110.108 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.62 -24.66 5.18 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.373 -1.491 . . . . 1.9099999999999999 109.373 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.47 HG22 HD13 ' A' ' 97' ' ' ILE . 4.3 pt -113.52 -176.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.493 -1.004 . . . . 3.1299999999999999 109.503 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -88.09 -168.47 2.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.62 -0.675 . . . . 4.3200000000000003 109.851 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.7 t -74.43 72.04 1.83 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.726 -0.609 . . . . 4.0199999999999996 109.423 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -73.68 65.31 0.98 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.9 -0.778 . . . . 4.0700000000000003 108.9 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.34 70.09 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.684 -1.367 . . . . 5.3099999999999996 109.684 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.66 75.54 1.54 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.605 -0.938 . . . . 5.9500000000000002 109.108 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.5 mtp -135.11 174.41 10.64 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.343 -0.848 . . . . 9.8100000000000005 109.156 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.77 51.65 1.74 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.427 -1.469 . . . . 9.9100000000000001 109.427 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 117.99 -1.005 . . . . 14.18 109.488 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.45 -0.574 . . . . 1.26 109.45 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -146.6 169.71 18.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 2.3700000000000001 109.498 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.05 83.45 1.83 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.613 -0.679 . . . . 0.92000000000000004 109.702 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -82.79 145.02 29.75 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.04 -0.726 . . . . 1.3500000000000001 109.04 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.664 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.24 129.35 5.54 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.124 -1.19 . . . . 0.48999999999999999 110.124 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 30.4 t80 -95.05 136.34 35.49 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.605 -0.887 . . . . 1.28 108.605 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.984 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.92 158.06 44.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.381 -0.824 . . . . 0.79000000000000004 110.359 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -155.84 130.25 8.92 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.762 -1.199 . . . . 1.9099999999999999 107.762 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.621 HG12 ' N ' ' A' ' 16' ' ' LEU . 28.2 m -85.4 145.75 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.428 -0.795 . . . . 0.76000000000000001 111.06 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t -120.51 -39.49 2.76 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.5 t -85.08 171.1 12.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 1.1200000000000001 109.445 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -114.08 53.6 0.78 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.561 -0.712 . . . . 1.6299999999999999 109.797 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -133.11 -57.51 0.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.376 -0.828 . . . . 2.5699999999999998 109.203 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -174.74 40.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.625 -0.88 . . . . 2.3999999999999999 108.625 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.585 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -58.44 -33.68 69.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.732 -0.605 . . . . 1.6399999999999999 110.142 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.766 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.5 tt -60.61 -42.3 96.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.267 -0.896 . . . . 0.58999999999999997 108.762 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.75 -49.3 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.52 -0.919 . . . . 1.25 108.52 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 15' ' ' SER . 9.6 mt -61.11 -38.66 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.699 -0.626 . . . . 0.51000000000000001 109.43 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 8.1 mm-40 -64.54 -53.89 40.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.175 -0.676 . . . . 2.1499999999999999 109.175 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.773 HG22 HG21 ' A' ' 33' ' ' ILE . 59.9 t -50.22 -49.43 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.694 -0.629 . . . . 0.32000000000000001 109.607 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -58.51 -31.46 67.91 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.6 -0.889 . . . . 3.9199999999999999 108.6 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.699 ' HB1' ' HG3' ' A' ' 64' ' ' LYS . . . -71.82 -40.08 69.38 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.079 -0.711 . . . . 0.37 109.079 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.984 HD11 ' HB2' ' A' ' 7' ' ' ALA . 7.8 mt -70.41 -44.49 67.81 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.484 -0.932 . . . . 1.1100000000000001 108.484 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.654 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.72 -45.43 93.98 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.001 -0.74 . . . . 1.76 109.001 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -59.79 -34.18 72.69 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.453 -0.943 . . . . 1.28 108.453 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.58 -32.81 70.34 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.185 -0.672 . . . . 0.44 109.185 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.56 45.85 0.26 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.35 -1.9 . . . . 0.5 108.35 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.664 HG11 ' HA3' ' A' ' 5' ' ' GLY . 93.8 t -119.64 145.77 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.927 -0.749 . . . . 0.59999999999999998 109.287 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.0 140.63 31.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 1.1000000000000001 109.159 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.68 -32.86 74.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.561 -0.712 . . . . 0.35999999999999999 109.346 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.4 -26.24 68.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.621 -0.674 . . . . 0.48999999999999999 109.34 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.37 65.56 0.64 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.467 -0.771 . . . . 1.76 109.388 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.773 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -117.49 87.51 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.34999999999999998 109.21 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -81.41 74.83 8.39 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.924 -0.769 . . . . 1.3700000000000001 108.924 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.755 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.3 t -78.95 178.06 8.29 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.403 0.621 . . . . 0.81999999999999995 110.124 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.61 107.27 5.9 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.145 -0.687 . . . . 1.3600000000000001 109.145 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.428 ' CE ' HD13 ' A' ' 16' ' ' LEU . 4.3 mmtp -72.41 65.55 0.64 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.734 . . . . 1.51 109.346 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.81 47.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.351 -0.843 . . . . 1.01 110.152 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -71.8 66.47 0.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -0.77 . . . . 1.8200000000000001 109.593 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.46 -154.47 6.15 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.349 -1.5 . . . . 2.0600000000000001 109.349 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -63.76 -33.29 75.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.976 . . . . 2.9199999999999999 109.311 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 m -153.03 -175.58 5.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 2.2200000000000002 109.319 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.16 128.02 34.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.466 -0.771 . . . . 1.8100000000000001 109.592 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.78 69.4 1.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 2.0099999999999998 109.387 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -74.98 74.08 2.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.401 -0.812 . . . . 3.2599999999999998 109.666 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -112.89 -21.27 11.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.448 -0.783 . . . . 2.4700000000000002 109.86 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.32 -68.34 1.73 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.777 -1.329 . . . . 0.68999999999999995 109.777 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -62.66 -30.4 71.35 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.646 -0.914 . . . . 1.49 108.824 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.595 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.4 t0 -59.52 -39.23 83.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 1.6100000000000001 109.314 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.414 HD23 ' CE ' ' A' ' 53' ' ' MET . 8.3 mt -92.04 -28.69 17.01 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.696 -0.853 . . . . 0.67000000000000004 108.696 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -62.07 -36.44 81.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.559 -0.713 . . . . 0.32000000000000001 109.117 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 32.6 mtp180 -61.53 -23.56 66.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.527 -0.733 . . . . 1.25 109.586 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.414 ' CE ' HD23 ' A' ' 50' ' ' LEU . 23.8 ptt? -112.82 4.24 16.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.491 -0.755 . . . . 2.4500000000000002 111.174 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -113.18 -25.06 9.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.073 -1.017 . . . . 1.8400000000000001 110.486 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 61' ' ' ILE . 30.0 m -62.56 146.25 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.373 -0.829 . . . . 0.93999999999999995 109.876 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -101.97 167.02 10.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.603 -0.686 . . . . 2.2799999999999998 109.242 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.01 111.2 3.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.414 -0.804 . . . . 2.1299999999999999 109.611 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.26 24.54 16.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.886 -1.286 . . . . 0.45000000000000001 109.886 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -91.26 157.12 17.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -1.083 . . . . 2.1400000000000001 109.525 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.71 126.69 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.556 -0.715 . . . . 1.04 109.176 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 55' ' ' VAL . 41.9 mt -103.48 99.8 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.997 -0.742 . . . . 0.32000000000000001 108.997 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HB2' HG22 ' A' ' 28' ' ' VAL . 3.6 mt -78.98 121.83 25.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.666 -0.646 . . . . 0.72999999999999998 109.376 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.86 139.75 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.507 -0.746 . . . . 1.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.699 ' HG3' ' HB1' ' A' ' 22' ' ' ALA . 7.4 tmtm? -99.74 162.83 12.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.594 -0.692 . . . . 3.77 109.331 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.37 85.49 2.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 3.7000000000000002 109.543 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.0 tp -106.49 -33.87 7.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.704 . . . . 1.54 109.245 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.06 -75.97 0.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.588 -0.695 . . . . 3.7799999999999998 109.426 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 179.85 138.6 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.629 -0.669 . . . . 4.5599999999999996 109.243 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HG ' ' CG ' ' A' ' 76' ' ' MET . 4.4 mm? -57.01 -66.51 0.44 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.534 -0.729 . . . . 1.46 110.276 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.75 -125.2 5.13 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.686 -1.365 . . . . 1.98 109.686 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -171.76 -59.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.639 -0.918 . . . . 6.29 109.488 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.01 -65.58 1.05 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.511 -0.743 . . . . 3.1200000000000001 109.496 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 74' ' ' ALA . 1.7 m -60.8 167.79 2.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.501 -0.749 . . . . 2.3199999999999998 109.707 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 73' ' ' THR . . . -76.71 62.08 1.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.622 -0.674 . . . . 1.02 109.58 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -78.79 -50.77 10.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 1.99 108.974 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.427 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 1.4 tmt? -56.24 -35.28 67.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 3.04 109.681 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.435 HD12 ' H ' ' A' ' 77' ' ' ILE . 4.7 mp -84.95 -20.23 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.756 -0.59 . . . . 0.82999999999999996 109.89 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -69.17 0.26 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.241 -0.912 . . . . 2.6099999999999999 109.433 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.671 ' C ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.19 -17.37 18.36 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.531 -0.731 . . . . 1.51 110.701 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.431 ' N ' HD22 ' A' ' 79' ' ' LEU . 55.9 mt -77.37 -42.35 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.838 -1.171 . . . . 1.3 107.838 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -70.33 -32.38 70.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.482 -0.933 . . . . 2.3500000000000001 108.482 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.35 -42.21 79.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.48 -0.563 . . . . 1.98 109.48 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 20.8 m-85 -76.27 -35.47 58.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -0.758 . . . . 1.3500000000000001 109.453 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.76 -35.24 75.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 1.3500000000000001 109.482 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.39 -23.82 37.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.694 -0.629 . . . . 0.66000000000000003 110.035 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.81 4.85 23.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 1.96 110.461 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.1 28.65 66.03 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.362 -1.495 . . . . 0.45000000000000001 109.362 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 59' ' ' ASP . 61.6 t -114.43 148.82 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.658 -0.907 . . . . 0.39000000000000001 109.045 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -104.4 164.73 11.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 0.59999999999999998 109.517 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 83' ' ' PHE . 48.8 mt -137.36 105.11 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.724 -0.843 . . . . 0.34999999999999998 108.724 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -77.63 153.79 32.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.529 -0.732 . . . . 2.2200000000000002 109.522 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.91 119.99 25.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.574 -0.703 . . . . 1.5800000000000001 109.879 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.4 -22.52 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.516 -0.74 . . . . 1.71 109.728 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -62.89 -26.29 68.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 2.7400000000000002 110.305 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -137.22 -44.04 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.337 -0.852 . . . . 2.9500000000000002 110.108 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.62 -24.66 5.18 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.373 -1.491 . . . . 1.9099999999999999 109.373 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 pt -113.52 -176.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.493 -1.004 . . . . 2.6499999999999999 109.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -88.09 -168.47 2.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.62 -0.675 . . . . 3.8399999999999999 109.851 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 99' ' ' THR . 5.7 t -74.43 72.04 1.83 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.726 -0.609 . . . . 3.6600000000000001 109.423 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -73.68 65.31 0.98 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.9 -0.778 . . . . 4.0700000000000003 108.9 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.34 70.09 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.684 -1.367 . . . . 5.3099999999999996 109.684 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.66 75.54 1.54 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.605 -0.938 . . . . 5.9500000000000002 109.108 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.5 mtp -135.11 174.41 10.64 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.343 -0.848 . . . . 9.4499999999999993 109.156 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.77 51.65 1.74 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.427 -1.469 . . . . 9.9100000000000001 109.427 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 117.99 -1.005 . . . . 13.859999999999999 109.488 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.45 -0.574 . . . . 1.26 109.45 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -146.6 169.71 18.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.608 -0.682 . . . . 2.37 109.498 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.05 83.45 1.83 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.613 -0.679 . . . . 0.92 109.702 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -82.79 145.02 29.75 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.04 -0.726 . . . . 1.35 109.04 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.664 ' HA3' HG11 ' A' ' 28' ' ' VAL . . . -132.24 129.35 5.54 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.124 -1.19 . . . . 0.49 110.124 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' CZ ' ' HG ' ' A' ' 48' ' ' LEU . 30.4 t80 -95.05 136.34 35.49 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.605 -0.887 . . . . 1.28 108.605 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.984 ' HB2' HD11 ' A' ' 23' ' ' LEU . . . -138.92 158.06 44.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.381 -0.824 . . . . 0.79 110.359 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -155.84 130.25 8.92 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.762 -1.199 . . . . 1.91 107.762 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.621 HG12 ' N ' ' A' ' 16' ' ' LEU . 28.2 m -85.4 145.75 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.428 -0.795 . . . . 0.76 111.06 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.8 t -120.51 -39.49 2.76 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.5 t -85.08 171.1 12.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 1.12 109.445 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -114.08 53.6 0.78 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.561 -0.712 . . . . 1.63 109.797 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -133.11 -57.51 0.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.376 -0.828 . . . . 2.57 109.203 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -174.74 40.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.625 -0.88 . . . . 2.4 108.625 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.585 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -58.44 -33.68 69.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.732 -0.605 . . . . 1.64 110.142 -179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.766 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.5 tt -60.61 -42.3 96.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.267 -0.896 . . . . 0.59 108.762 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.75 -49.3 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.52 -0.919 . . . . 1.25 108.52 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 15' ' ' SER . 9.6 mt -61.11 -38.66 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.699 -0.626 . . . . 0.51 109.43 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 8.1 mm-40 -64.54 -53.89 40.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.175 -0.676 . . . . 2.15 109.175 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.773 HG22 HG21 ' A' ' 33' ' ' ILE . 59.9 t -50.22 -49.43 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.694 -0.629 . . . . 0.32 109.607 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -58.51 -31.46 67.91 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.6 -0.889 . . . . 3.92 108.6 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.699 ' HB1' ' HG3' ' A' ' 64' ' ' LYS . . . -71.82 -40.08 69.38 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.079 -0.711 . . . . 0.37 109.079 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.984 HD11 ' HB2' ' A' ' 7' ' ' ALA . 7.8 mt -70.41 -44.49 67.81 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.484 -0.932 . . . . 1.11 108.484 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.654 ' HE3' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -61.72 -45.43 93.98 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.001 -0.74 . . . . 1.76 109.001 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -59.79 -34.18 72.69 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.453 -0.943 . . . . 1.28 108.453 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.58 -32.81 70.34 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.185 -0.672 . . . . 0.44 109.185 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.56 45.85 0.26 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.35 -1.9 . . . . 0.5 108.35 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.664 HG11 ' HA3' ' A' ' 5' ' ' GLY . 93.8 t -119.64 145.77 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.927 -0.749 . . . . 0.6 109.287 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.0 140.63 31.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.599 -0.688 . . . . 1.1 109.159 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.68 -32.86 74.01 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.561 -0.712 . . . . 0.36 109.346 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.4 -26.24 68.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.621 -0.674 . . . . 0.49 109.34 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.37 65.56 0.64 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.467 -0.771 . . . . 1.76 109.388 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.773 HG21 HG22 ' A' ' 20' ' ' VAL . 43.5 mm -117.49 87.51 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.476 -0.765 . . . . 0.35 109.21 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -81.41 74.83 8.39 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.924 -0.769 . . . . 1.37 108.924 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.755 HG21 ' CD1' ' A' ' 16' ' ' LEU . 5.3 t -78.95 178.06 8.29 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.403 0.621 . . . . 0.82 110.124 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -138.61 107.27 5.9 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.145 -0.687 . . . . 1.36 109.145 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.428 ' CE ' HD13 ' A' ' 16' ' ' LEU . 4.3 mmtp -72.41 65.55 0.64 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.734 . . . . 1.51 109.346 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.81 47.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.351 -0.843 . . . . 1.01 110.152 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -71.8 66.47 0.55 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -0.77 . . . . 1.82 109.593 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.46 -154.47 6.15 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.349 -1.5 . . . . 2.06 109.349 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 m -63.76 -33.29 75.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.54 -0.976 . . . . 2.92 109.311 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 m -153.03 -175.58 5.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.662 -0.649 . . . . 2.22 109.319 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.16 128.02 34.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.466 -0.771 . . . . 1.81 109.592 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.78 69.4 1.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 2.01 109.387 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -74.98 74.08 2.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.401 -0.812 . . . . 3.26 109.666 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -112.89 -21.27 11.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.448 -0.783 . . . . 2.47 109.86 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.32 -68.34 1.73 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.777 -1.329 . . . . 0.69 109.777 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -62.66 -30.4 71.35 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.646 -0.914 . . . . 1.49 108.824 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.595 ' H ' HD12 ' A' ' 48' ' ' LEU . 3.4 t0 -59.52 -39.23 83.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.516 -0.74 . . . . 1.61 109.314 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.414 HD23 ' CE ' ' A' ' 53' ' ' MET . 8.3 mt -92.04 -28.69 17.01 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.696 -0.853 . . . . 0.67 108.696 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 55' ' ' VAL . 7.4 tp -62.07 -36.44 81.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.559 -0.713 . . . . 0.32 109.117 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HA ' ' CE1' ' A' ' 83' ' ' PHE . 32.6 mtp180 -61.53 -23.56 66.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.527 -0.733 . . . . 1.25 109.586 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.414 ' CE ' HD23 ' A' ' 50' ' ' LEU . 23.8 ptt? -112.82 4.24 16.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.491 -0.755 . . . . 2.45 111.174 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -113.18 -25.06 9.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.073 -1.017 . . . . 1.84 110.486 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.487 HG11 HD11 ' A' ' 61' ' ' ILE . 30.0 m -62.56 146.25 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.373 -0.829 . . . . 0.94 109.876 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -101.97 167.02 10.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.603 -0.686 . . . . 2.28 109.242 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.01 111.2 3.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.414 -0.804 . . . . 2.13 109.611 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.26 24.54 16.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.886 -1.286 . . . . 0.45 109.886 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -91.26 157.12 17.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -1.083 . . . . 2.14 109.525 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.71 126.69 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.556 -0.715 . . . . 1.04 109.176 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.487 HD11 HG11 ' A' ' 55' ' ' VAL . 41.9 mt -103.48 99.8 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.997 -0.742 . . . . 0.32 108.997 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HB2' HG22 ' A' ' 28' ' ' VAL . 3.6 mt -78.98 121.83 25.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.666 -0.646 . . . . 0.73 109.376 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.86 139.75 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.507 -0.746 . . . . 1.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.699 ' HG3' ' HB1' ' A' ' 22' ' ' ALA . 7.4 tmtm? -99.74 162.83 12.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.594 -0.692 . . . . 3.77 109.331 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.37 85.49 2.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 3.7 109.543 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.0 tp -106.49 -33.87 7.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.573 -0.704 . . . . 1.54 109.245 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.06 -75.97 0.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.588 -0.695 . . . . 3.78 109.426 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 179.85 138.6 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.629 -0.669 . . . . 4.56 109.243 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HG ' ' CG ' ' A' ' 76' ' ' MET . 4.4 mm? -57.01 -66.51 0.44 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.534 -0.729 . . . . 1.46 110.276 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.75 -125.2 5.13 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.686 -1.365 . . . . 1.98 109.686 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -171.76 -59.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.639 -0.918 . . . . 6.29 109.488 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.01 -65.58 1.05 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.511 -0.743 . . . . 3.12 109.496 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 74' ' ' ALA . 1.7 m -60.8 167.79 2.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.501 -0.749 . . . . 2.32 109.707 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 73' ' ' THR . . . -76.71 62.08 1.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.622 -0.674 . . . . 1.02 109.58 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -78.79 -50.77 10.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 1.99 108.974 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.427 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 1.4 tmt? -56.24 -35.28 67.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 3.04 109.681 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 77' ' ' ILE . 4.7 mp -84.95 -20.23 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.756 -0.59 . . . . 0.83 109.89 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.56 -69.17 0.26 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.241 -0.912 . . . . 2.61 109.433 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.671 HD22 ' C ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -58.19 -17.37 18.36 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.531 -0.731 . . . . 1.51 110.701 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.431 ' N ' HD22 ' A' ' 79' ' ' LEU . 55.9 mt -77.37 -42.35 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.838 -1.171 . . . . 1.3 107.838 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -70.33 -32.38 70.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.482 -0.933 . . . . 2.35 108.482 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.35 -42.21 79.55 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.48 -0.563 . . . . 1.98 109.48 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 52' ' ' ARG . 20.8 m-85 -76.27 -35.47 58.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.487 -0.758 . . . . 1.35 109.453 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.76 -35.24 75.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 1.35 109.482 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.39 -23.82 37.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.694 -0.629 . . . . 0.66 110.035 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.81 4.85 23.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.391 -0.818 . . . . 1.96 110.461 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.1 28.65 66.03 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.362 -1.495 . . . . 0.45 109.362 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 59' ' ' ASP . 61.6 t -114.43 148.82 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.658 -0.907 . . . . 0.39 109.045 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -104.4 164.73 11.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.658 -0.651 . . . . 0.6 109.517 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 83' ' ' PHE . 48.8 mt -137.36 105.11 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.724 -0.843 . . . . 0.35 108.724 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -77.63 153.79 32.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.529 -0.732 . . . . 2.22 109.522 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.91 119.99 25.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.574 -0.703 . . . . 1.58 109.879 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.4 -22.52 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.516 -0.74 . . . . 1.71 109.728 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -62.89 -26.29 68.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 2.74 110.305 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -137.22 -44.04 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.337 -0.852 . . . . 2.95 110.108 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.62 -24.66 5.18 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.373 -1.491 . . . . 1.91 109.373 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 pt -113.52 -176.43 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.493 -1.004 . . . . 2.65 109.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 m -88.09 -168.47 2.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.62 -0.675 . . . . 3.84 109.851 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.558 HG23 ' O ' ' A' ' 99' ' ' THR . 5.7 t -74.43 72.04 1.83 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.726 -0.609 . . . . 3.66 109.423 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -73.68 65.31 0.98 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.9 -0.778 . . . . 4.07 108.9 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.34 70.09 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.684 -1.367 . . . . 5.31 109.684 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.66 75.54 1.54 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.605 -0.938 . . . . 5.95 109.108 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.5 mtp -135.11 174.41 10.64 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.343 -0.848 . . . . 9.45 109.156 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.77 51.65 1.74 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.427 -1.469 . . . . 9.91 109.427 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 117.99 -1.005 . . . . 13.86 109.488 -179.922 . . . . . . . . 0 0 . 1 stop_ save_